Skip to main content
. 2020 Feb 15;20:57. doi: 10.1186/s12883-020-01633-3

Fig. 3.

Fig. 3

Forest plot of CGRP mAb vs. placebo for the changes in baseline monthly acute migraine-specifc medication days. The estimated pooled WMD was − 1.28 (95% CI, − 1.66 to − 0.90) with high statistical significance (P < 0.00001). There was high heterogeneity among the studies (I2 = 77%). SD standard deviation, CI confidence interval, WMD weighted mean difference